Colgate-Palmolive (NYSE:CL) Shares Sold by Sigma Planning Corp

Sigma Planning Corp lessened its position in Colgate-Palmolive (NYSE:CL) by 49.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,770 shares of the company’s stock after selling 5,596 shares during the quarter. Sigma Planning Corp’s holdings in Colgate-Palmolive were worth $460,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in CL. &PARTNERS lifted its stake in Colgate-Palmolive by 0.7% in the fourth quarter. &PARTNERS now owns 17,643 shares of the company’s stock valued at $1,406,000 after buying an additional 129 shares during the last quarter. West Branch Capital LLC boosted its stake in Colgate-Palmolive by 24.0% during the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after purchasing an additional 132 shares during the period. First Foundation Advisors boosted its stake in Colgate-Palmolive by 2.7% during the 3rd quarter. First Foundation Advisors now owns 5,226 shares of the company’s stock worth $372,000 after purchasing an additional 136 shares during the period. Waldron Private Wealth LLC grew its position in Colgate-Palmolive by 2.7% during the 3rd quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock worth $381,000 after purchasing an additional 140 shares during the last quarter. Finally, Autumn Glory Partners LLC increased its stake in Colgate-Palmolive by 2.7% in the fourth quarter. Autumn Glory Partners LLC now owns 5,319 shares of the company’s stock valued at $424,000 after purchasing an additional 140 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on CL. Barclays raised their price target on Colgate-Palmolive from $82.00 to $84.00 and gave the stock an “equal weight” rating in a report on Friday, April 12th. Citigroup boosted their target price on Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, April 16th. StockNews.com downgraded Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. UBS Group boosted their price objective on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, January 29th. Finally, JPMorgan Chase & Co. raised their target price on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the stock an “overweight” rating in a research note on Thursday, January 18th. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $89.50.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, EVP Gregory Malcolm sold 8,930 shares of the company’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $85.35, for a total value of $762,175.50. Following the sale, the executive vice president now owns 8,043 shares of the company’s stock, valued at $686,470.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Colgate-Palmolive news, EVP Gregory Malcolm sold 8,930 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $85.35, for a total transaction of $762,175.50. Following the completion of the transaction, the executive vice president now owns 8,043 shares of the company’s stock, valued at $686,470.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now owns 274,179 shares in the company, valued at $22,797,983.85. The disclosure for this sale can be found here. In the last three months, insiders sold 232,371 shares of company stock worth $19,505,099. 0.34% of the stock is owned by corporate insiders.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $89.27 on Friday. The firm has a market capitalization of $73.38 billion, a price-to-earnings ratio of 32.11, a price-to-earnings-growth ratio of 3.33 and a beta of 0.42. The company has a debt-to-equity ratio of 8.59, a current ratio of 1.11 and a quick ratio of 0.71. The business’s 50 day simple moving average is $87.51 and its 200-day simple moving average is $81.30. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $90.37.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The company had revenue of $4.95 billion for the quarter, compared to the consensus estimate of $4.89 billion. During the same period in the previous year, the business earned $0.77 earnings per share. Colgate-Palmolive’s quarterly revenue was up 6.9% compared to the same quarter last year. As a group, equities analysts forecast that Colgate-Palmolive will post 3.5 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.24%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio is presently 71.94%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.